ClinicalTrials.gg
DrugRead study by study

Vepdegestrant clinical trials

Also written ARV-471 and PF-07850327.

studies test it
23
open now
2
in phase 3
2
first study started
2010
ClinicalTrials.gov finds 21 studies for vepdegestrant. How that becomes 23 here

Every study that search finds has been read, to see whether and how it gives vepdegestrant. ClinicalTrials.gov counts as of Nov 17, 2026. How drug pages count

  1. 21Found by its intervention search · See all 21 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 16 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. +4Give it under a name that search misses: a biosimilar’s code or a misspelling
  3. 25Give vepdegestrant to participants
  4. −2Give it beside what is tested
  5. 23Test it: the count on this site

Get an email when these change. Save the vepdegestrant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
1 May 2026 · VEPPANU · NDA 219835 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

vepdegestrant
11
ARV-471, PF-07850327
3

Development codes

ARV-471
12
PF-07850327
7

Studies by the year they started

23 studies that test it; most in 2023 (10)

Studies that test vepdegestrant, by start year
YearStudies
20101
20191
20223
202310
20246
20252

By phase

A phase 1/2 study counts in both.

Phase 1
19
Phase 2
7
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 1

Pfizer (19) · Arvinas Estrogen Receptor, Inc. (2) · Arvinas Inc. (1) · QuantumLeap Healthcare Collaborative (1)

Often tested with

Tested in the same studies.

Atirmociclib (1) · Midazolam (1) · Everolimus (1) · Itraconazole (1) · Esomeprazole (1) · Carbamazepine (1) · Trastuzumab (1) · Ganitumab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

New treatments tested with it · 1 most studied

New when their studies opened, with vepdegestrant beside them; studies of each.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test vepdegestrant, phase 3 first.

Studies

Open first, then newest update. How each study uses vepdegestrant has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 23

See all 23 studies that test vepdegestrant →

Behind its US label · 1 — the studies the FDA label of VEPPANU describes

From the Clinical Studies section of VEPPANU (2026-06), as openFDA has it. A study the site does not hold is left out.

Tested on its own · 7 — no other medicine in its arm
Tested with established drugs · 6 — they are given beside it
Tested in a combination · 10 — another drug in the study is under test too
Beside a new treatment under test · 1 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with vepdegestrant: prifetrastat 1

One option of several · 1 — a test or a strategy chooses among drugs

Codes

What other systems call vepdegestrant · ClinicalTrials.gg INT002220

  • MeSH (NLM) C000732096vepdegestrantOne source NLM
  • UNII (FDA) WC1U3R1YMIVEPDEGESTRANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q123965022vepdegestrantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C165420VepdegestrantOne source FDA
  • DrugBank DB19006One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion